ACCD | Accolade, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	6.90 - 6.94
52 Week Range	3.08 - 11.16
Beta	2.46
Implied Volatility	43.53%
IV Rank	19.64%
Day's Volume	705,168
Average Volume	2,038,774
Shares Outstanding	81,884,200
Market Cap	567,457,506
Sector	Healthcare
Industry	Medical - Healthcare Information Services
IPO Date	2020-07-01

Valuation
Profitability
Growth
Health
P/E Ratio	-3.04
Forward P/E Ratio	N/A
EPS	-2.28
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	2,400
Country	USA
Website	ACCD

Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.

ACCD's peers: PRVA, HSTM, NRC, CPSI, NXGN, HCAT, DH, PINC, CERT, PHR, AGTI, EVH, CMAX, RCM, DOCS, GDRX, OPRX, RPTX, SDGR, TDOC, VEEV

*Chart delayed

Analyzing fundamentals for ACCD we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see ACCD Fundamentals page.

Watching at ACCD technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on ACCD Technicals page.